Medical Devices
Wireless PRIMA retinal implant improves central vision for many patients with advanced geographic atrophy, trial reports
Imeripotiwa na AI Picha iliyoundwa na AI Imethibitishwa ukweli
A 2×2 millimeter wireless retinal implant system helped many people with advanced geographic atrophy due to age-related macular degeneration regain functional central vision in a multicenter European study, according to results published in The New England Journal of Medicine.
Oura's chief medical officer, Dr. Ricky Bloomfield, said the company's Symptom Radar feature has prompted the discovery of multiple lymphoma cases by alerting users to vital sign deviations. The tool, originally developed during the COVID-19 pandemic, has also led to early detections of appendicitis and other conditions. Bloomfield highlighted the feature's role in encouraging timely medical consultations.
Imeripotiwa na AI
Scientists have developed a light-based sensor that can identify tiny amounts of cancer biomarkers in blood samples, potentially enabling earlier detection than traditional scans. The technology combines DNA nanostructures, CRISPR, and quantum dots to produce a clear signal from just a few molecules. Tests on lung cancer patient serum showed promising results at sub-attomolar levels.
The FDA granted several breakthrough device designations in September 2025 for innovative medical technologies. These designations expedite the development and review of devices addressing unmet needs. Updates include new approvals and predetermined change control plans.